top of page
HOME
ABOUT US
SOCIAL IMPACT
STRATEGY
GENE THERAPY
CELL THERAPY
RNA-BASED THERAPY
TARGETED THERAPIES
MICROBIOME
TEAM
PORTFOLIO
VENTURE PORTFOLIO
PAST PORTFOLIO
NEWSROOM
CONTACT
More
Use tab to navigate through the menu items.
CONTACT
20 North Audley St.,
London W1K 6WE
United Kingdom
T: +44 (0) 203 940 6646
info@4biocapital.com
Press Enquiries
Consilium Strategic Communications
+44 (0) 20 3709 5700
info@consilium-comms.com
Investor Enquiries - North America
AccessAlpha Worldwide LLC
+1 (312) 585 6000
rob.leclercq@accessalpha.com
NAME
EMAIL
MESSAGE
Success! Message received.
SEND
bottom of page
